newsfilter
← Latest News
Business Wire·

The American Journal of Psychiatry Publishes Data Demonstrating Akili Interactive's Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults with Major Depressive Disorder When Combined with Antidepressant Medication

AKL-T03 showed a statistically significant improvement in sustained attention compared to control intervention AKL-T03 is built on the same technology engine as Akili's digital therapeutic EndeavorRx, which has been cleared by the U.S. Food and Drug